Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States is a research paper published in Clinical Infectious Diseases (2022). On theSindex it has a DataRank of 0. It has been cited 19 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: K23 GM129661
NHLBI NIH HHS
Grant: K23 HL153584
NCATS NIH HHS
Grant: UL1 TR002369
National Institutes of Health
Grant: 5K23HL153584-05
Bag-Mask Ventilation to PreVent Hypoxemia during Tracheal Intubation in the Emergency Department: A Clinical Trial
National Institutes of Health
Grant: 5K23AI137321-03
Longitudinal Analysis of the Fecal Microbiome and Resistome of Patients with Multidrug-Resistant Urinary Tract Infections and Predictors of Recurrence
National Institutes of Health
Grant: 4UH3HL141722-02
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)
National Institutes of Health
Grant: 5K12HL133117-05
The Vanderbilt Emergency Care Research Training Program
United States Centers for Disease Control and Prevention
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals